Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Ovarian Neoplasms

  Free Subscription


22.05.2017

1 Ann Oncol
1 Cancer Chemother Pharmacol
1 Cancer Res
14 Gynecol Oncol
2 Int J Gynaecol Obstet


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Oncol

  1. CONDORELLI R, Andre F
    Combining PI3K and PARP inhibitors for breast and ovarian cancer tratement.
    Ann Oncol. 2017 May 15. doi: 10.1093.
    PubMed     Text format    


    Cancer Chemother Pharmacol

  2. WANG YY, Chen YK, Hu SC, Hsu YL, et al
    CYT-Rx20 inhibits ovarian cancer cells in vitro and in vivo through oxidative stress-induced DNA damage and cell apoptosis.
    Cancer Chemother Pharmacol. 2017 May 12. doi: 10.1007/s00280-017-3330.
    PubMed     Text format     Abstract available


    Cancer Res


  3. Correction: Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma.
    Cancer Res. 2017;77:2770.
    PubMed     Text format    


    Gynecol Oncol

  4. SZUBERT S, Wojtowicz A, Moszynski R, Zywica P, et al
    External validation of the IOTA ADNEX model performed by two independent gynecologic centers.
    Gynecol Oncol. 2016 Jun 30. pii: S0090-8258(16)30831.
    PubMed     Text format     Abstract available

  5. ATASEVEN B, Chiva LM, Harter P, Gonzalez-Martin A, et al
    FIGO stage IV epithelial ovarian, fallopian tube and peritoneal cancer revisited.
    Gynecol Oncol. 2016 Jun 19. pii: S0090-8258(16)30824.
    PubMed     Text format     Abstract available

  6. RAUH-HAIN JA, Birrer M, Del Carmen MG
    "Carcinosarcoma of the ovary, fallopian tube, and peritoneum: Prognostic factors and treatment modalities".
    Gynecol Oncol. 2016 Jun 16. pii: S0090-8258(16)30771.
    PubMed     Text format     Abstract available

  7. ROQUE DR, Makowski L, Chen TH, Rashid N, et al
    Association between differential gene expression and body mass index among endometrial cancers from The Cancer Genome Atlas Project.
    Gynecol Oncol. 2016 Jun 8. pii: S0090-8258(16)30811.
    PubMed     Text format     Abstract available

  8. ESSELEN KM, Terry KL, Samuel A, Elias KM, et al
    Endosalpingiosis: More than just an incidental finding at the time of gynecologic surgery?
    Gynecol Oncol. 2016 Jun 2. pii: S0090-8258(16)30765.
    PubMed     Text format     Abstract available

  9. JORGE S, Jones NL, Chen L, Hou JY, et al
    Characteristics, treatment and outcomes of women with immature ovarian Teratoma, 1998-2012.
    Gynecol Oncol. 2016 May 21. pii: S0090-8258(16)30753.
    PubMed     Text format     Abstract available

  10. DE LA MOTTE ROUGE T, Pautier P, Genestie C, Rey A, et al
    Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors.
    Gynecol Oncol. 2016 Jul 8. pii: S0090-8258(16)30862.
    PubMed     Text format     Abstract available

  11. CHAN JK, Gardner AB, Chan JE, Guan A, et al
    The influence of age and other prognostic factors associated with survival of ovarian immature teratoma - A study of 1307 patients.
    Gynecol Oncol. 2016 Jul 13. pii: S0090-8258(16)30835.
    PubMed     Text format     Abstract available

  12. BROWN AJ, Shen MJ, Urbauer D, Taylor J, et al
    Room for improvement: An examination of advance care planning documentation among gynecologic oncology patients.
    Gynecol Oncol. 2016 Jul 18. pii: S0090-8258(16)30879.
    PubMed     Text format     Abstract available

  13. GAO B, Lindemann K, Anderson L, Fereday S, et al
    Serous ovarian and primary peritoneal cancers: A comparative analysis of clinico-pathological features, molecular subtypes and treatment outcome.
    Gynecol Oncol. 2016 Jul 18. pii: S0090-8258(16)30834.
    PubMed     Text format     Abstract available

  14. TANENBAUM LM, Mantzavinou A, Subramanyam KS, Del Carmen MG, et al
    Ovarian cancer spheroid shrinkage following continuous exposure to cisplatin is a function of spheroid diameter.
    Gynecol Oncol. 2017 May 9. pii: S0090-8258(17)30795.
    PubMed     Text format     Abstract available

  15. GARCIA C, Yao A, Camacho F, Balkrishnan R, et al
    A SEER-Medicare analysis of the impact of metformin on overall survival in ovarian cancer.
    Gynecol Oncol. 2017 May 9. pii: S0090-8258(17)30847.
    PubMed     Text format     Abstract available

  16. COHEN JG, Prendergast E, Geddings JE, Walts AE, et al
    Evaluation of venous thrombosis and tissue factor in epithelial ovarian cancer.
    Gynecol Oncol. 2017 May 10. pii: S0090-8258(17)30802.
    PubMed     Text format     Abstract available

  17. BARBER EL, Doll KM, Gehrig PA
    Hospital readmission after ovarian cancer surgery: Are we measuring surgical quality?
    Gynecol Oncol. 2017 May 15. pii: S0090-8258(17)30851.
    PubMed     Text format     Abstract available


    Int J Gynaecol Obstet

  18. LIU R, Cheng J, Chen Y, Wang W, et al
    Potential role and prognostic importance of dishevelled-2 in epithelial ovarian cancer.
    Int J Gynaecol Obstet. 2017 May 17. doi: 10.1002/ijgo.12218.
    PubMed     Text format     Abstract available

  19. BATTARBEE A, Strohl A, Zimmerman L, Patel A, et al
    Applicability of the modified ACOG/SGO referral criteria for adnexal mass within a limited-resource setting.
    Int J Gynaecol Obstet. 2017;136:53-57.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: